. Status of the grafted ovarian tissue, treated with or without vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2), two and three weeks after subcutaneous transplantation.
Tissue Status
Control The cryopreserved mouse ovarian tissues were autologously transplanted to the subcutaneous site of the inguinal region. Half of the ovarian tissues treated with VEGF/FGF2 were implanted into one side of the subcutaneous space, and the other half ones without treatment of VEGF/FGF2 were inserted into the opposite side of the same mouse. Two or three weeks after transplantation, ovarian grafts were retrieved for analysis of the tissue status. The fibrosis or survival rate was defined as the percentage of ovarian grafts absorbed or present at the retrieval time relative to the total ovarian grafts. The untreated control group or the VEGF/FGF2-treated group was counted independently. Three weeks after transplantation, mice (n = 24) grafted with ovarian tissue were treated with 150 IU gonadotropins. Oocytes were retrieved from antral follicles of the ovarian grafts. Six independent experiments were performed. GV, germinal vesicle; MI, metaphase I; MII, metaphase II.
